Evidence map›Paper›PMID 25251829›Full record

ArticleChemical communications (Cambridge, England)2014

Esterase-activated release of naproxen from supramolecular nanofibres.

Martin Conda-Sheridan, Sungsoo S Lee, Adam T Preslar, Samuel I Stupp

Abstract read
In one paragraph

Article in Chemical communications (Cambridge, England), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.7field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 44 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Martin Conda-SheridanSimpson Querrey Institute for BioNanotechnology, Northwestern University, Chicago, IL 60611, USA. s-stupp@northwestern.edu.
Sungsoo S Lee
Adam T Preslar
Samuel I Stupp
Northwestern University · US

Funding

Regenerative Scaffold Technologies for CNS and DiabetesR01EB003806 · NIBIB · NORTHWESTERN UNIVERSITY AT CHICAGO · PI STUPP, SAMUEL I · 2004 to 2015
$10.7M
Nanotechnology Strategies for Growth of Bones and TeethR01DE015920 · NIDCR · NORTHWESTERN UNIVERSITY AT CHICAGO · PI SNEAD, MALCOLM L., STUPP, SAMUEL I · 2005 to 2015
$5.8M
NIBIB NIH HHS 5R01EB003806-09NIBIB NIH HHS R01 EB003806NIDCR NIH HHS 2R01DE015920-09NIDCR NIH HHS R01 DE015920
6 · The paper itself

Abstract

Nanofibre forming peptide amphiphiles were conjugated to naproxen through an esterase-sensitive linker. The amount of naproxen released, in the presence of enzymes, was influenced by the linker conjugating the drug to the supramolecular assembly. In vitro studies showed the anti-inflammatory activity of the released drug was maintained.

Indexed as

AnimalsCell SurvivalCyclooxygenase 2Cyclooxygenase 2 InhibitorsEsterasesMesenchymal Stem CellsMiceMicroscopy, Electron, TransmissionNanofibersNaproxenPeptidesCyclooxygenase 2Cyclooxygenase 2 InhibitorsEsterasesNaproxenPeptides

Identifiers

PMID25251829
PMCPMC4201510
OpenAlexW2120672759

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.